Khodadoust line

From WikiMD's WELLNESSPEDIA


Khodadoust line
Synonyms
Pronounce N/A
Specialty Ophthalmology
Symptoms Corneal edema, blurred vision
Complications Corneal graft rejection
Onset
Duration
Types N/A
Causes Immune response to corneal transplant
Risks Previous corneal transplantation
Diagnosis Slit lamp examination
Differential diagnosis
Prevention
Treatment Topical corticosteroids, immunosuppressive therapy
Medication N/A
Prognosis Variable, depending on response to treatment
Frequency
Deaths N/A


Khodadoust Line is a clinical sign observed in corneal transplantation, named after Dr. Irvine Khodadoust, a pioneer in the field of ophthalmology. It is a line of immune cells that migrate towards the corneal graft, indicating a rejection response.

Definition[edit]

The Khodadoust Line is defined as a line of leukocytes (white blood cells) that migrate towards a corneal graft in the event of a rejection response. This line is usually visible in the corneal endothelium, the innermost layer of the cornea. The presence of the Khodadoust Line is a significant indicator of graft rejection in corneal transplantation.

History[edit]

The Khodadoust Line is named after Dr. Irvine Khodadoust, an Iranian-American ophthalmologist who first described this clinical sign in 1970. Dr. Khodadoust's extensive research in corneal transplantation and graft rejection has significantly contributed to the field of ophthalmology.

Clinical Significance[edit]

The presence of the Khodadoust Line is a clear sign of graft rejection following corneal transplantation. It is one of the earliest signs of rejection and is often accompanied by other symptoms such as decreased vision, redness, and pain. Early detection of the Khodadoust Line allows for prompt treatment, which can significantly improve the prognosis of the graft.

Treatment[edit]

The primary treatment for a rejection response indicated by the Khodadoust Line is the administration of corticosteroids, either topically or systemically. In severe cases, additional immunosuppressive therapy may be required. Early detection and treatment are crucial to prevent irreversible damage to the graft.

See Also[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.